Amylin: What might be its role in alzheimer's disease and how could this affect therapy?

Florin Despa, Charles Decarli

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations
Original languageEnglish
Pages (from-to)403-405
Number of pages3
JournalExpert Review of Proteomics
Volume10
Issue number5
DOIs
StatePublished - 2013

Bibliographical note

Funding Information:
F Despa is supported by 1R01HL118474-01A1, NSF CBET-1133339, ADA 1-13-IN-70 and AHA 13GRNT16470034. C DeCarli is supported by NIA P30 AG10129. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Funding

F Despa is supported by 1R01HL118474-01A1, NSF CBET-1133339, ADA 1-13-IN-70 and AHA 13GRNT16470034. C DeCarli is supported by NIA P30 AG10129. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

FundersFunder number
National Science Foundation (NSF)CBET-1133339, ADA 1-13-IN-70
National Institute on AgingP30 AG10129
National Heart, Lung, and Blood Institute (NHLBI)R01HL118474
American Historical Association 13GRNT16470034

    Keywords

    • Alzheimer's disease
    • amylin
    • amyloid
    • cerebrovascular disease
    • dementia
    • hyperamylinemia
    • hyperinsulinemia
    • insulin resistance
    • obesity
    • type 2 diabetes

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Biology

    Fingerprint

    Dive into the research topics of 'Amylin: What might be its role in alzheimer's disease and how could this affect therapy?'. Together they form a unique fingerprint.

    Cite this